Parallel Advisors, LLC Precision Biosciences Inc Transaction History

Parallel Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$7.4 - $11.66 $540 - $851	-73 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$9.18 - $14.15 $9,721 - $14,984	-1,059 Reduced 93.55%	73 $1,000
Q2 2021 Aug 06, 2021	BUY	$8.07 - $12.52 $1,065 - $1,652	132 Added 13.2%	1,132 $14,000
Q3 2019 Nov 01, 2019	SELL	$8.03 - $14.82 $59,421 - $109,668	-7,400 Reduced 88.1%	1,000 $8,000
Q2 2019 Aug 05, 2019	BUY	$11.88 - $16.94 $99,792 - $142,296	8,400 New	8,400 $111,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $842M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.